NCT04190433View on ClinicalTrials.gov

Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 1, 2020

Primary Completion Date

April 18, 2023

Study Completion Date

April 18, 2023

Conditions
Breast CarcinomaHematopoietic and Lymphoid Cell NeoplasmLymphomaSarcoma
Interventions
DRUG

Carvedilol

Given PO

DRUG

Lisinopril

Given PO

DRUG

Pravastatin

Given PO

DRUG

Spironolactone

Given PO

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT04190433 - Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial | Biotech Hunter | Biotech Hunter